Home
Scholarly Works
Cctg BL12: Randomized phase II trial comparing...
Journal article

Cctg BL12: Randomized phase II trial comparing nab-paclitaxel (Nab-P) to paclitaxel (P) in patients (pts) with advanced urothelial cancer progressing on or after a platinum containing regimen (NCT02033993).

Authors

Sridhar SS; Blais N; Tran B; Reaume MN; North SA; Stockler MR; Chi KN; Fleshner NE; Liu G; Robinson JW

Journal

Journal of Clinical Oncology, Vol. 36, No. 15_suppl, pp. 4505–4505

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2018

DOI

10.1200/jco.2018.36.15_suppl.4505

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team